Purple Man

Purple Man
A man with purple skin, wearing a suit
Purple Man as seen on the cover of New Thunderbolts #10 (September 2005).
Art by Tom Grummett.
Publication information
PublisherMarvel Comics
First appearanceDaredevil #4 (November 1964)[1]
Created byStan Lee
Joe Orlando
In-story information
Alter egoZebediah Killgrave
SpeciesHuman
Abilities
  • Skilled manipulator
  • High-level intellect
  • Mind control
  • Regeneration

The Purple Man (Zebediah Killgrave) is a supervillain appearing in American comic books published by Marvel Comics. Created by writer Stan Lee and artist Joe Orlando, he first appeared in Daredevil #4 (October 1964). His body produces pheromones which allow him to verbally control the actions of others, and occasionally break the fourth wall for sinister effect. His stories typically involve him brainwashing other characters. Initially a recurring enemy of Daredevil, he later became the archenemy of Jessica Jones.

A modified version of the character named Kevin Thompson/Kilgrave was portrayed by David Tennant in the Netflix television series Jessica Jones set in the Marvel Cinematic Universe (MCU), for which Tennant received critical praise,[2][3] and for which the character was included in Rolling Stone's list of the "40 Greatest TV Villains of All Time"[4] while IGN ranked him #79 of the "Top 100 Villains".

  1. ^ Misiroglu, Gina Renée; Eury, Michael (2006). The Supervillain Book: The Evil Side of Comics and Hollywood. Visible Ink Press. ISBN 9780780809772.
  2. ^ Mueller, Matthew (February 24, 2016). "Saturn Awards 2016 Nominees Announced". ComicBook.com. Archived from the original on February 25, 2016. Retrieved February 24, 2016.
  3. ^ Shepherd, Jack (November 12, 2015). "Marvel's Jessica Jones, first half review: 'David Tennant's Kilgrave could be the best on-screen comic book villain since Heath Ledger's Joker'". The Independent.
  4. ^ Collins, Sean T. (February 9, 2016). "40 Greatest TV Villains of All Time". Rolling Stone. Archived from the original on July 22, 2017. Retrieved April 29, 2016.